Q2 2024 · 13F-HR
Velan Capital Investment Management LPholdings as filed
Filed 2024-08-14 · accession 0001848809-24-000007
$174.6M
Reported value
17
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 016259202 | — | ALIMERA SCIENCES INC | $75.7M | 43.3% | 13,608,533 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $32.5M | 18.6% | 1,471,904 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $24.5M | 14.0% | 6,986,744 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $14.5M | 8.31% | 350,666 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $4.1M | 2.35% | 319,080 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $3.5M | 2.01% | 746,087 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $3.4M | 1.97% | 800,000 | Common | SOLE |
| 83086J200 | SKYE | SKYE BIOSCIENCE INC | $3.4M | 1.94% | 422,142 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $2.6M | 1.49% | 2,492,830 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $2.6M | 1.48% | 1,290,323 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $2.3M | 1.29% | 904,029 | Common | SOLE |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $1.8M | 1.04% | 247,084 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $1.6M | 0.92% | 597,299 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $998,400 | 0.57% | 480,000 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $513,337 | 0.29% | 122,223 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $382,232 | 0.22% | 659,020 | Common | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $187,500 | 0.11% | 625,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.